Leading companies and regulatory agencies adopt LifeSphere Intake and Triage, the principal application of LSMV suite
MIAMI, FL. October 3, 2018 – ArisGlobal, a leading life sciences technology provider, announced the launch of LifeSphere MultiVigilance – the next-generation platform for individual case safety report (ICSR) intake powered by LifeSphere Nava – ArisGlobal’s cognitive computing engine. LifeSphere MultiVigilance is developed on a completely new, cutting-edge technology architecture designed for the cloud with the latest robotic automation and cognitive computing technologies including natural language processing (NLP) and machine learning to transform all pharmacovigilance (PV) activities.
LifeSphere MultiVigilance is also the first and only unified platform fully integrated with product quality complaints and medical information management, delivering a new dimension on compliance with seamless exchange of safety cases between these critical functions.
ArisGlobal has been partnering with leading pharmaceutical companies and regulatory agencies to develop the new platform. Together, ArisGlobal and its strategic partners focused on identifying business critical problems within safety case processing, and then identified innovative ways to solve these problems. Each of the PV platform’s automation functions were extensively tested during the development process by ArisGlobal’s PV and IT experts, with additional PV expertise provided by its partners.
LifeSphere Intake and Triage will transform into a fully functional safety system by Q3 2019, which Boehringer Ingelheim, one of ArisGlobal’s strategic automation partners, will implement. The new PV platform will replace legacy ARISg, and migration of its multi-tenant customer base to the new platform will occur over the next 12-18 months.
“LifeSphere MultiVigilance is the only production ready, cognitive computing enabled, case intake platform available today that can integrate with any type of safety system. This platform not only simplifies safety case processing but also leads to significant cost savings for all marketing authorization holders. We believe this platform is a game-changer for the industry, as our customers will achieve cost savings greater than 30% with higher data quality and compliance,” said Sankesh Abbhi, President and CEO, ArisGlobal. “No other platform can deliver this type of performance.”
Boehringer Ingelheim has been working closely with ArisGlobal on LifeSphere MultiVigilance. “We are extremely excited and optimistic about the quality and productivity gains that this technology will provide,” said Claudia Lehmann, Head of PV Operations, Boehringer Ingelheim. “We have seen how the platform’s advanced robotic automation and cognitive features will allow us to automate many of our key PV steps in the area of case processing, which are currently resource intensive.”
For more on LifeSphere Intake and Triage: https://www.arisglobal.com/products/lifesphere-intake-and-triage/.
ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.